Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2025 Apr 29;18(1):88.
doi: 10.1186/s13048-025-01624-3.

The impact of preoperative immunonutritional status on postoperative complications in ovarian cancer

Affiliations
Multicenter Study

The impact of preoperative immunonutritional status on postoperative complications in ovarian cancer

Xingyu Liu et al. J Ovarian Res. .

Abstract

Background: Preoperative immunonutritional status can influence postoperative complications. Malnutrition in ovarian cancer patients diminishes the body's resilience to abdominal surgery, resulting in inferior surgical outcomes and increased postoperative complications. We aim to investigate the effect of preoperative immunonutritional status, including NLR, PLR, LMR, TCLR, FAR, FLR, SII, PNI and CONUT on postoperative complications in epithelial ovarian cancer (EOC) in a large population.

Methods: A multicenter real-world study included 922 patients with histologically confirmed EOC who received comprehensive staged surgery or debulking surgery at seven tertiary hospitals in China between 2012 and 2023. Logistic regression and Lasso regression analyses were employed to identify variables associated with postoperative complications. A predictive nomogram model was developed based on multivariate modeling.

Results: The study included a total of 922 patients diagnosed with epithelial ovarian cancer across seven medical centers with 565 (61.3%) patients experiencing postoperative complications. Significant differences were found in the distribution of inflammatory and nutritional risk indicators, including NLR, PLR, LMR, TCLR, FAR, FLR, SII, PNI and CONUT between the two groups (all P < 0.01). A multivariable model identified several predictive factors for postoperative complications: PNI > 46.73 (odds ratio [OR] = 0.49, P < 0.001), FAR > 10.77 (OR = 1.60, P = 0.019), LMR > 3.70 (OR = 0.68, P = 0.044), hydrothorax (OR = 2.60, P = 0.005), laparoscopy (OR = 0.59, P = 0.010 vs. laparotomy), enterectomy (OR = 2.50, P = 0.001).

Conclusion: Poor immunonutritional status can increase the risk of postoperative complications. These findings suggest that prompt nutritional interventions may reduce the incidence of postoperative complications and improve surgical outcomes. The risk prediction model, including PNI, FAR, LMR, hydrothorax, laparoscopy vs. laparotomy, and enterectomy, might facilitate patient-centered decision-making and risk stratification.

Clinical trial registration: The study was registered in the Clinical trial registry: NCT06483399. ( https://clinicaltrials.gov/study/NCT06483399 ).

Keywords: Ovarian cancer; Postoperative complications; Preoperative immunonutritional status.

PubMed Disclaimer

Conflict of interest statement

Declarations. Ethics approval and consent to participate: This study was approved by the Research Ethics Commission of Tongji Medical College of Huazhong University of Science and Technology (TJ-IRB202401053) and the consent was waived. Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Flow chart of patient inclusion and exclusion
Fig. 2
Fig. 2
Lasso regression analysis of variables associated with postoperative complications. (A) Dynamic variation of Lasso regression coefficients, (B) Tenfold cross-validation for LASSO model parameter adjustment using Lambda.1se criteria. Lasso, Least absolute shrinkage and seletion operator; MSE, Mean-squared error
Fig. 3
Fig. 3
The nomogram for predicting the risk of postoperative complications. FAR, Fibrinogen to albumin ratio; LMR, Lymphocyte to monocyte ratio; PNI, Prognostic nutritional index
Fig. 4
Fig. 4
Evaluation of the prediction model in the training and validation sets. (A) Receiver operating characteristic (ROC) curve for the training set, (B) Calibration curve for the training set, (C) Decision curve analysis (DCA) for the training set, (D) ROC curve for the internal validation set, (E) Calibration curve for the internal validation set, (F) DCA for the internal validation set

References

    1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer statistics 2020: GLOBOCAN estimates of incidence and Mortality Worldwide for 36 cancers in 185 countries. Cancer J Clin. 2021;71:209–49. 10.3322/caac.21660. - PubMed
    1. du Bois A, Reuss A, Pujade-Lauraine E, Harter P, Ray-Coquard I, Pfisterer J. Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: a combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials: by the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR) and the Groupe d’Investigateurs Nationaux Pour Les Etudes des Cancers de l’Ovaire (GINECO). Cancer. 2009;115:1234–44. 10.1002/cncr.24149. - PubMed
    1. Manning-Geist BL, Hicks-Courant K, Gockley AA, Clark RM, Del Carmen MG, Growdon WB, Horowitz NS, Berkowitz RS, Muto MG, Worley MJ. Jr. A novel classification of residual disease after interval debulking surgery for advanced-stage ovarian cancer to better distinguish oncologic outcome. Am J Obstet Gynecol. 2019;221:326e1. 10.1016/j.ajog.2019.05.006. - PubMed
    1. Chang SJ, Hodeib M, Chang J, Bristow RE. Survival impact of complete cytoreduction to no gross residual disease for advanced-stage ovarian cancer: a meta-analysis. Gynecol Oncol. 2013;130:493–8. 10.1016/j.ygyno.2013.05.040. - PubMed
    1. Xu Z, Becerra AZ, Justiniano CF, Aquina CT, Fleming FJ, Boscoe FP, Schymura MJ, Sinno AK, Chaoul J, Morrow GR, et al. Complications and Survivorship trends after primary debulking surgery for ovarian Cancer. J Surg Res. 2020;246:34–41. 10.1016/j.jss.2019.08.027. - PMC - PubMed

Publication types

Associated data

Grants and funding